Results 161 to 170 of about 414,209 (326)
Opportunities and Challenges of Population Pharmacogenomics
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou+3 more
wiley +1 more source
EXPERIMENTAL TREATMENT INVOLVING APITHERAPY IN HEREDITARY HEMOLYTIC ANEMIA
Hemolytic anemia is a form of anemia in which red blood cells are destroyed and removed from the bloodstream before their usual lifespan is up. Anemia appears because the red blood cells are destroyed faster than the bone marrow can produce them.
Calin Vasile ANDRITOIU+5 more
doaj
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott+3 more
wiley +1 more source
Autoimmune hemolytic anemia (AIHA) is an unusual complication of malignancy. We diagnosed primary splenic anaplastic large cell lymphoma (ALCL) in a patient. A seven-year-old boy presented with Coombs test-positive hemolytic anemia. After a course
Yavuz Köksal+4 more
doaj
Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
Microangiopathic hemolytic anemia (MAHA) is a rare subtype of hemolytic anemia characterized by elevated hemolytic markers and red blood cell destruction.
Syedda Ayesha+4 more
doaj +1 more source
Autoimmune hemolytic anemia (AIHA) is a classic example of type II hypersensitivity, caused by autoantibodies that bind red blood cells (RBC). The autoantibodies can be divided into cold or warm types, depending on the optimum temperature at which they bind, and AIHA can also be classified as either primary or secondary if there is an underlying ...
Robert N. Barker, Mark A. Vickers
openaire +2 more sources
Thromboelastographic assessment of the contribution of platelets and clotting proteases to the hypercoagulable state of dogs with immune-mediated hemolytic anemia: Platelet contribution to hypercoagulability in IMHA [PDF]
Chan, D L, Hamzianpour, N
core +1 more source
T cell receptor repertoire analysis by high‐throughput immune repertoire RNA‐sequencing in the patients with DOCK8 deficiency. Comprehensive comparisons revealed a restricted TCR repertoire diversity in the patients. Additional assessments showed potential auto‐reactive CD8+ T cell clones in the patients.Abbreviations: DOCK8, dedicator of cytokinesis ...
Ceren Bozkurt+26 more
wiley +1 more source
Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper
ABSTRACT Antiplatelet drug (APD) therapy is the cornerstone for the prevention of atherosclerotic cardiovascular disease. The main APDs are aspirin and thienopyridines, particularly clopidogrel. These drugs may induce hypersensitivity reactions (HSRs).
Gabriele Cortellini+10 more
wiley +1 more source
Reproductive functions and fertility preservation in men with sickle cell disease
Abstract Background Sickle cell disease (SCD) is a prevalent hereditary disorder with significant morbidity, including potential impacts on male fertility. This study aims to evaluate the semen parameters in men with SCD and assess the outcomes of fertility preservation strategies.
Clarisse Leblanc+12 more
wiley +1 more source